• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

19
2
2
2
1

COUNTRY

2
1

PRICE

9
10
15
25

PUBLISHED

3
3
6
25

PRODUCT TYPE

25

Bladder Cancer

Bladder cancer is the fourth most common cancer among males in the US and due to its prevalence among the over 65s, diagnoses are set to increase in ageing populations worldwide. Reports in the Bladder Cancer section cover a variety of areas, such as the latest R&D and clinical trials taking place in universities, hospitals and other research centres around the world. Explore epidemiology, unmet needs, drug development (cytotoxic, immunotherapy agents, etc.), supply & demand, business development strategies, licensing and partnership opportunities, and the activities of key industry players such as Bristol-Myers Squibb, Spectrum Pharmaceuticals, Bioniche Life Sciences, Endo Pharmaceuticals, Eli Lilly and Sanofi-Aventis. Show Less Read more

PRODUCT TITLE
Bladder Cancer Drug Pipeline Update 2014 Bladder Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

Bladder Cancer Drug Pipeline Update 2014

According to the American Cancer Society, bladder cancer is the 6th most common cancer in the U.S. Bladder cancer occurs among both men and women. When found and treated early, the 5 year survival rate...

March 2014
Bladder Cancer Drug Pathway Analyzer 2014 Bladder Cancer Drug Pathway Analyzer 2014 - Product Thumbnail Image

Bladder Cancer Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 99 targeted molecular therapies known to affect more than 215 specific intracellular signaling pathways...

March 2014
Hematological Cancers Drug Pathway Analyzer 2014 Hematological Cancers Drug Pathway Analyzer 2014 - Product Thumbnail Image

Hematological Cancers Drug Pathway Analyzer 2014

Extra value: One year of free online updates included with this product There are today at least 672 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways...

March 2014

OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017

Bladder cancer is a urologic malignancy arising from the epithelial lining of the urinary bladder Although it is the ninth most common cancer worldwide in men and women, with the highest recurrence...

December 2013
FROM

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2022 Summary With more than 12 million new cases occurring worldwide each year, bladder cancer is estimated to be the ninth most common cancer,...

November 2013
FROM
Bladder Cancer – Executive Market Summary 2013 Bladder Cancer – Executive Market Summary 2013 - Product Thumbnail Image

Bladder Cancer – Executive Market Summary 2013

The Bladder Cancer Executive Market Summary 2013 provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide,...

May 2013
FROM
Global Bladder Cancer Pipeline Capsule - 2013 Global Bladder Cancer Pipeline Capsule - 2013 - Product Thumbnail Image

Global Bladder Cancer Pipeline Capsule - 2013

Fore Pharma’s latest report ‘Global Bladder Cancer Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global bladder cancer market. It covers...

April 2013
FROM
09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

09 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in September 2012 All companies include technology, market(s), key...

September 2012
FROM
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012 All companies include technology, market(s), key executive,...

June 2012
FROM
Bladder Cancer – Executive Market Summary 2011 Bladder Cancer – Executive Market Summary 2011 - Product Thumbnail Image

Bladder Cancer – Executive Market Summary 2011

Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format These reports are prepared by the senior market...

May 2012
FROM
05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

05 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 41 emerging medical technology companies that have been identified by LSI's in-house research team in May 2012 All companies include technology, market(s), key executive,...

May 2012
FROM
04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 37 emerging medical technology companies that have been identified by LSI's in-house research team in April 2012 All companies include technology, market(s), key executive,...

April 2012
FROM
03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

03 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 61 emerging medical technology companies that have been identified by LSI's in-house research team in March 2012 All companies include technology, market(s), key executive,...

March 2012
FROM
02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

02 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 43 emerging medical technology companies that have been identified by LSI's in-house research team in February 2012 All companies include technology, market(s), key executive,...

February 2012
FROM
Global Bladder Cancer Drug Pipeline Capsule - 2012 Global Bladder Cancer Drug Pipeline Capsule - 2012 - Product Thumbnail Image

Global Bladder Cancer Drug Pipeline Capsule - 2012

Fore Pharma’s latest report ‘Global Bladder Cancer Drug Pipeline Capsule – 2012’ is an outline of all the key research and development (R&D) activities of the global bladder cancer drug market. It covers...

January 2012
FROM
01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities 01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities - Product Thumbnail Image

01 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 47 emerging medical technology companies that have been identified by LSI's in-house research team in January 2012 All companies include technology, market(s), key executive,...

January 2012
FROM

Bladder Cancer Global Clinical Trials Review, H2, 2011

Bladder Cancer Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2011" provides data on the Bladder Cancer clinical...

August 2011
FROM
Global Bladder Cancer Drug Pipeline Capsule - 2011 Global Bladder Cancer Drug Pipeline Capsule - 2011 - Product Thumbnail Image

Global Bladder Cancer Drug Pipeline Capsule - 2011

Fore Pharma's latest report ‘Global Bladder Cancer Drug Pipeline Capsule – 2011' is an outline of all the key research and development (R&D) activities of the global bladder cancer drug market It covers...

August 2011
FROM
2011 U.S. Markets for External Radiation Therapy 2011 U.S. Markets for External Radiation Therapy - Product Thumbnail Image

2011 U.S. Markets for External Radiation Therapy

2011 U S Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data -...

May 2011
FROM
2011 Global Markets for External Radiation Therapy 2011 Global Markets for External Radiation Therapy - Product Thumbnail Image

2011 Global Markets for External Radiation Therapy

2011 Global Markets for External Radiation Therapy is a comprehensive market intelligence solution designed for senior executives who are looking for: - High quality, granular, deeply segmented data...

May 2011
FROM
Loading Indicator

Our Clients

Our clients' logos